|Articles|September 9, 2022
Meet the FDA Diversity Action Plan Guidance
Author(s)Science 37
In this whitepaper, Science 37's Diversity & Inclusion leaders share strategies on how to achieve diversity in clinical trials in order to adhere to the FDA's Guidance.
Related Content
Trending on Applied Clinical Trials Online
1
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
2
ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation
3
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
4
ACT Brief: Simplifying Trials Through Selective Safety Data, AI-Driven Site Partnerships, and Biopharma Strategic Pivots
5